Sanna Kettunen - UEFConnect

Refine your search

Information Publications

Research groups

Keywords

atherosclerosis atherosclerotic cardiovascular diseases in vivo models

Publications

9/9 items

The mechanisms of Chr.9p21.3 risk locus in coronary artery disease – where are we today?
Ruotsalainen, Anna-Kaisa; Kettunen, Sanna; Suoranta, Tuisku; Kaikkonen, Minna U; Ylä-Herttuala, Seppo; Aherrahrou, Rédouane. 2025. American journal of physiology : heart and circulatory physiology. 328: H196-H208 A2 Review article, Literature review, Systematic review
Deletion of the Murine Ortholog of the Human 9p21.3 Locus Leads to Insulin Resistance and Obesity in Hypercholesterolemic Mice
Kettunen, Sanna; Suoranta, Tuisku; Beikverdi, Sadegh; Heikkilä, Minja; Slita, Anna; Räty, Iida; Ylä-Herttuala, Elias; Öörni, Katariina; Ruotsalainen, Anna-Kaisa; Ylä-Herttuala, Seppo. 2024. Cells. 13: A1 Journal article (refereed), original research
Ex vivo imaging of subacute myocardial infarction with ultra-short echo time 3D quantitative T1- and T1ρ-mapping magnetic resonance imaging in mice
Räty, Iida; Aarnio, Antti; Nissi, Mikko J; Kettunen, Sanna; Ruotsalainen, Anna-Kaisa; Laidinen, Svetlana; Ylä-Herttuala, Seppo; Ylä-Herttuala, Elias. 2024. European heart journal : imaging methods and practice. 3: 1-10 A1 Journal article (refereed), original research
Deletion of the murine ortholog of human 9p21.3 locus promotes atherosclerosis by increasing macrophage proinflammatory activity
Kettunen, Sanna; Ruotsalainen, Anna-Kaisa; Örd, Tiit; Suoranta, Tuisku; Heikkilä, Janne; Kaikkonen, Minna U.; Laham-Karam, Nihay; Ylä-Herttuala, Seppo. 2023. Frontiers in cardiovascular medicine. 10: . 1113890 A1 Journal article (refereed), original research
Lymphatic insufficiency leads to distinct myocardial infarct content assessed by magnetic resonance TRAFFn, T1ρ and T2 relaxation times
Ylä-Herttuala, Elias; Vuorio, Taina; Kettunen, Sanna; Laidinen, Svetlana; Ylä-Herttuala, Seppo; Liimatainen, Timo. 2023. Scientific reports. 13: . 1579 A1 Journal article (refereed), original research
RNA interference-based therapies for the control of atherosclerosis risk factors
Kettunen, Sanna; Ruotsalainen, Anna-Kaisa; Ylä-Herttuala, Seppo. 2022. Current opinion in cardiology. 37: 364-371 A2 Review article, Literature review, Systematic review
SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice
Gurzeler, Erika; Ruotsalainen, Anna-Kaisa; Laine, Anssi; Valkama, Teemu; Kettunen, Sanna; Laakso, Markku; Ylä-Herttuala, Seppo. 2021. PLoS ONE. 16: e025840 A1 Journal article (refereed), original research
Deletion of Lymphangiogenic and Angiogenic Growth Factor VEGF-D Leads to Severe Hyperlipidemia and Delayed Clearance of Chylomicron Remnants
Tirronen, Annakaisa; Vuorio, Taina; Kettunen, Sanna; Hokkanen, Krista; Ramms, Bastian; Niskanen, Henri; Laakso, Hanne; Kaikkonen, Minna U; Jauhiainen, Matti; Gordts, Philip LSM; Ylä-Herttuala, Seppo. 2018. Arteriosclerosis, thrombosis, and vascular biology. 38: 2327-2337 A1 Journal article (refereed), original research
The follow-up of progressive hypertrophic cardiomyopathy using magnetic resonance rotating frame relaxation times
Khan, Muhammad Arsalan; Laakso, Hanne; Laidinen, Svetlana; Kettunen, Sanna; Heikura, Tommi; Ylä-Herttuala, Seppo; Liimatainen, Timo. 2017. Nmr in biomedicine. 2018; 31: e3871 A1 Journal article (refereed), original research